Breakthrough Results From New HIV Injection Offer Hope For Prevention A major study shows twice-yearly lenacapavir injections can prevent HIV infections among young women, prompting calls for affordable access. In a groundbreaking development in HIV prevention, a new drug regimen has emerged from clinical trials, offering a beacon of hope for vulnerable populations. "This appears to be a new breakthrough for HIV prevention. Interestingly, the quest for an effective HIV vaccine has provided foundational insights for rapid vaccine developments seen during the COVID-19 pandemic. Persistent obstacles such as stigma, misinformation, and lack of access to healthcare resources remain barriers to global HIV prevention strategies.

Source: Washington Post July 25, 2024 12:55 UTC